Figure 6
Figure 6. miR-146a in human GVHD. (A-B) The rs2910164 SNP genotype was analyzed in 286 HCT donors using Taqman realtime PCR assays. (A) Frequency of donors with the CC genotype vs the non-CC genotype in the group of patients with no/mild GVHD (grade 0-II) and severe GVHD (grade III-IV), respectively, is shown. Frequency of the CC genotype was higher in HCT donors of patients developing severe GVHD compared with no/mild GVHD. (B) Mean GVHD severity in recipients that have received hematopoietic cells from allogeneic donors with the CC genotype vs without the CC genotype is shown.

miR-146a in human GVHD. (A-B) The rs2910164 SNP genotype was analyzed in 286 HCT donors using Taqman realtime PCR assays. (A) Frequency of donors with the CC genotype vs the non-CC genotype in the group of patients with no/mild GVHD (grade 0-II) and severe GVHD (grade III-IV), respectively, is shown. Frequency of the CC genotype was higher in HCT donors of patients developing severe GVHD compared with no/mild GVHD. (B) Mean GVHD severity in recipients that have received hematopoietic cells from allogeneic donors with the CC genotype vs without the CC genotype is shown.

Close Modal

or Create an Account

Close Modal
Close Modal